ZYVERSA THERAPEUTICS
ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs. Our focus is on patients with inflammatory or renal diseases who have significant unmet medical needs. Our development pipeline includes a novel inflammasome inhibitor with potential to treat multiple inflammatory diseases, and phase 2a-ready VAR 200, a cholesterol efflux mediator for treatment of a rare kidney disease, focal segmental glomerulosclerosis (FSGS), with potential to treat other kidney diseases.
ZYVERSA THERAPEUTICS
Social Links:
Industry:
Health Care Health Diagnostics Medical
Founded:
2014-01-01
Address:
Weston, Florida, United States
Country:
United States
Website Url:
http://www.zyversa.com
Total Employee:
11+
Status:
Active
Total Funding:
23.7 M USD
Technology used in webpage:
Amazon IPv6 Amazon S3 Akamai Hosted
Similar Organizations
Clincierge
Clincierge enables patients to connect more effectively with clinical trials of new medicines.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Sebela Pharmaceuticals
Sebela is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals.
Current Employees Featured
Founder
Stock Details
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - ZyVersa Therapeutics
Official Site Inspections
http://www.zyversa.com Semrush global rank: 6.29 M Semrush visits lastest month: 1.05 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
